Inside the Race to Detect Neurodegenerative Disease Early

Early detection of neurodegenerative diseases is vital for patient outcomes.

Amprion focuses on diagnostics for Alzheimer's, Parkinson's, and Huntington’s diseases.

SAAmplify-αSyn assay shows exceptional accuracy in detecting biomarkers.

The test can identify active disease years before clinical diagnosis.

Precision medicine is emerging as a diagnostic approach.

Innovations in AI and biomarker science are shaping future diagnostics.

80 million people worldwide live with neurodegenerative diseases.